Targeted therapies and immunotherapies have radically improved treatment for advanced
non-small-cell lung cancer (NSCLC). Tyrosine kinase inhibitors targeting oncogenic driver …

The applications of nanotechnology in medical sciences, especially in drug and gene
delivery, has experienced unprecedented growth in recent years. The integration of …

When breast cells divide and multiply out of control, it is called breast cancer. Symptoms
include lump formation in the breast, a change in the texture or color of the breast, or a …

Cancer stem cells (CSCs) are believed to be the main cause of chemotherapy resistance
and tumor relapse. Various therapeutic strategies to eliminate CSCs have been developed …

With the booming development of precision medicine, molecular targeted therapy has been
widely used in clinical oncology treatment due to a smaller number of side effects and its …

While new targeted therapies have considerably changed the treatment and prognosis of
non-small cell lung cancer (NSCLC), they are frequently unsuccessful due to primary or …

Regulated induced proximity targeting chimeras (RIPTACs), a new class of
heterobifunctional molecules, show promise in specifically targeting and eliminating cancer …

Ginkgo nuts have been traditionally consumed as food and medicine throughout the world.
However, people usually only use the kernel of ginkgo nuts as food source and the Ginkgo …

Background: Topoisomerase I is an enzyme that plays a crucial part in DNA replication and
transcription by the relaxation of supercoiled double-stranded DNA. Topoisomerase I …

Background: Apoptotic cells' phosphoserine (PS) groups have a significant
immunosuppressive effect. They inhibit proinflammatory signals by interacting with various …